Canada Markets open in 2 hrs 14 mins

PFE Mar 2023 47.500 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
2.9700-0.1300 (-4.19%)
As of 11:10AM EDT. Market open.
Full screen
Previous Close3.1000
Expire Date2023-03-17
Day's Range2.9700 - 2.9700
Contract RangeN/A
Open Interest115
  • Yahoo Finance

    Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing Wednesday

    Moderna CEO Stéphane Bancel is set to face Sen. Bernie Sanders to defend the company's fast growth and planned price hike of its COVID-19 vaccine.

  • Reuters

    US declines to force lower price on cancer drug Xtandi

    The U.S. government will not force Pfizer Inc and Astellas Pharma Inc to lower the price of their prostate cancer drug Xtandi using its emergency "march-in" authority, the National Institutes of Health (NIH) said on Tuesday. Xtandi's wholesale cost is between $160,000-$180,000 per patient a year. Patient group the Union for Affordable Cancer Treatment first filed a petition calling on the NIH to use its authority to lower the drug's price in March 2016.

  • Business Wire

    Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analysts

    NEW YORK, March 21, 2023--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, May 2, 2023. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s First Quarter 2023 Performance Report, to be issued that morning.